FNAM OTC
Evolutionary Genomics, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000199999995-0.45
Volume300
Avg Volume277
Beta-0.12
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSteven Bryan Warnecke
Employees2
SectorHealthcare
IndustryBiotechnology
IPO Date2011-04-08
Websiteevolgen.com
4220 Morning Star Drive
Castle Rock, CO 80108
US
Castle Rock, CO 80108
US
720 900 8666
About Evolutionary Genomics, Inc.
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Messier Walter | M-Exempt | 100,000 | — | 2022-05-23 |
| WARNECKE STEVE B | M-Exempt | 66,667 | — | 2022-05-23 |
| Orndorff Virginia P. | M-Exempt | 20,000 | — | 2022-05-23 |
| Messier Walter | F-InKind | 78,571 | $0.70 | 2022-05-23 |
| WARNECKE STEVE B | M-Exempt | 66,667 | $0.55 | 2022-05-23 |